Detalhe da pesquisa
1.
Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post-BCR inhibitor setting: a UK wide analysis.
Br J Haematol
; 185(4): 656-669, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30768675
2.
Results of a multicentre UK-wide retrospective study evaluating the efficacy of pixantrone in relapsed, refractory diffuse large B cell lymphoma.
Br J Haematol
; 173(6): 896-904, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26956150
3.
Idelalisib-rituximab induces durable remissions in TP53 disrupted B-PLL but results in significant toxicity: updated results of the UK-wide compassionate use programme.
Br J Haematol
; 184(4): 667-671, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29468637
4.
Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma.
Br J Haematol
; 181(4): 555-559, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28342183
5.
Idelalisib-Rituximab induces clinical remissions in patients with TP53 disrupted B cell prolymphocytic leukaemia.
Br J Haematol
; 177(3): 486-491, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27061924
6.
Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.
Bone Marrow Transplant
; 56(3): 605-613, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33004942
7.
First case of near haploid philadelphia negative B-Cell acute lymphoblastic leukaemia relapsing as acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.
Leuk Res Rep
; 14: 100213, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32612922
8.
Autoimmune Cytopenias Developing Late Post Alemtuzumab-Based Allogeneic Stem Cell Transplantation: Presentation of Short Case Series from a Transplant Center.
Cell Transplant
; 29: 963689720950641, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32806929
9.
Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.
Bone Marrow Transplant
; 57(2): 330, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34773088
10.
Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation.
Leuk Lymphoma
; 61(1): 202-205, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31402762
11.
Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma: reflections on a single center experience.
Leuk Lymphoma
; 60(12): 3075-3077, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31079514